Maresin-1 Protects Against Parkinson's Disease in Rats
Author Information
Author(s): Khodir Suzan A., Sweed Eman M., Faried Manar A., Abo Elkhair Doaa M., Khalil Marwa M., Afifi Khaled Hatem, El Agamy Dalia Fathy
Primary Institution: Menoufia University, Egypt
Hypothesis
The study aimed to evaluate the protective effects of Maresin-1 in rotenone-induced Parkinson's disease and its association with the JAK/STAT signaling pathway.
Conclusion
Maresin-1 effectively alleviated motor impairments and biochemical alterations induced by rotenone in rats, suggesting its potential as a neuroprotective agent.
Supporting Evidence
- Maresin-1 treatment improved motor function in rats with Parkinson's disease.
- Inflammatory markers were significantly reduced in the ROT + MaR1 group compared to the ROT group.
- Histopathological analysis showed less neuronal degeneration in the ROT + MaR1 group.
- Biochemical evaluations indicated increased levels of neurotrophic factors in the ROT + MaR1 group.
Takeaway
Maresin-1 is like a superhero for rats with Parkinson's disease, helping them move better and feel less sick after being exposed to a harmful chemical.
Methodology
Thirty male Wistar rats were divided into control, ROT-treated, and ROT + MaR1-treated groups, undergoing various motor behavioral tests and biochemical evaluations.
Limitations
The study did not include a group treated with only Maresin-1 to compare its effects independently.
Participant Demographics
Thirty male Wistar rats, aged 8-12 weeks, weighing 200-220 g.
Statistical Information
P-Value
p<0.05
Confidence Interval
95%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website